SCHEMBL2915006

SCHEMBL2915006

Nc1cc(CO)c2[nH]cnc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.38
PARP1 P09874 3/20 0.38
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
RAD52 P43351 1/20 0.37
ALDH1A1 P00352 2/20 0.36
APEX1 P27695 1/20 0.36
RECQL P46063 1/20 0.36
BLM P54132 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PNP P00491 4/20 0.33
CYP19A1 P11511 1/20 0.32
ABL1 P00519 1/20 0.32
RIN1 Q13671 1/20 0.32
PI4KA P42356 2/20 0.32
PI4K2B Q8TCG2 2/20 0.32
PI4K2A Q9BTU6 2/20 0.32
PI4KB Q9UBF8 2/20 0.32
LMNA P02545 1/20 0.32
DRD3 P35462 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7093035 0.82 ELANE (0.39) PRKCIPARP1KDM4EMAPTRAD52
SCHEMBL7091970 0.77 CDK1 (0.38) PRKCIMAPT
SCHEMBL3071570 0.76 PRKCI (0.41) PRKCIPARP1KDM4EMAPTRAD52
SCHEMBL28871077 0.75 ALDH1A1 (0.47) PRKCIPARP1KDM4EMAPTRAD52
SCHEMBL2919854 0.72 CYP3A4 (0.46) PARP1KDM4EMAPTALDH1A1TDP1
SCHEMBL7032609 0.72 PRKCI (0.41) PRKCIPARP1KDM4EMAPTRAD52
SCHEMBL7035006 0.72 PRKCI (0.41) PRKCIPARP1KDM4EMAPTRAD52
SCHEMBL28272777 0.72 PRKCI (0.41) PRKCIPARP1KDM4EMAPTRAD52
SCHEMBL7028875 0.72 PRKCI (0.41) PRKCIPARP1KDM4EMAPTRAD52
SCHEMBL7090538 0.72 PRKCI (0.41) PRKCIPARP1KDM4EMAPTRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311965-A1 2-AMINOQUINAZOLINE DERIVATIVE CARNA BIOSCIENCES INC. (JP) 2010-12-09 US disclosed
EP-2226315-A1 2-AMINOQUINAZOLINE DERIVATIVE Carna Biosciences Inc. (JP) 2010-09-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311965-A1 2-AMINOQUINAZOLINE DERIVATIVE DSTYK, ABL1, EEF2K PRKCI 84/4885PARP1 1719/4885KDM4E 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.